Literature DB >> 28189264

Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion.

Vahid Tavakolian Ferdousie1, Maryam Mohammadi2, Gholamhossein Hassanshahi3, Hossein Khorramdelazad4, Soudeh Khanamani Falahati-Pour4, Mohsen Mirzaei5, Mohammad Allah Tavakoli6, Zahra Kamiab7, Zahra Ahmadi8, Reza Vazirinejad9, Effat Shahrabadi8, Ioanna Koniari10, Nicholas G Kounis10, Ali Esmaeili Nadimi11.   

Abstract

BACKGROUND: Cardiovascular disease constitutes a major cause of death worldwide. Inflammation plays an important role in atherosclerosis formation, coronary artery disease progression, acute coronary thrombosis and occlusion. Chemokines are inflammatory mediators disposing several bio-functions, as leukocyte migration towards inflammatory signals and vascular injuries. The present study was designed to evaluate the potential correlation between serum levels of chemokines CXCL-10 and CXCL-12 and the degree of coronary artery occlusion.
METHODS: Eighty eight patient candidates for coronary angiography with coronary artery disease symptoms and potentially high risk of coronary artery occlusion were recruited. Chemokine serum levels were measured with the ELISA method and patients underwent coronary angiography. All patients with coronary artery disease (CAD) were divided into four groups according to the Gensini score. Data were presented as mean±SD. All P values <0.05 were considered significant.
RESULTS: Our demographic data showed that of the 88 patients, 46 were male and 42 female. The mean age of patients was 57.95±11.13. Following increased coronary artery occlusion the serum levels of chemokines were significantly increased (CXCL-10 and CXCL-12; P<0.0001 and P<0.0001, respectively).
CONCLUSION: In this novel study, a significant correlation between the serum levels of CXCL-10 and CXCL-12 and the severity of coronary artery occlusion was found. This could be attributed to the role of these chemokines in the processes of angiogenesis and angiostasis, a biological phenomenon that can play key role in the development of collateral circulation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Angiostasis; Chemokines; Coronary artery occlusion

Mesh:

Substances:

Year:  2017        PMID: 28189264     DOI: 10.1016/j.ijcard.2017.02.011

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  22 in total

1.  Circulatory Levels of C-X-C Motif Chemokine Ligands 1, 9, and 10 Are Elevated in Patients with Ischemic Stroke.

Authors:  Masoud Amin; Alireza Vakilian; Mohammad Hossein Mahmoodi; Gholamhossein Hassanshahi; Soudeh Khanamani Falahati-Pour; Maryam Rafiei Dolatabadi; Ali Esmaeili Nadimi
Journal:  Eurasian J Med       Date:  2017-06

Review 2.  An integrated approach to coronary heart disease diagnosis and clinical management.

Authors:  Teresa Infante; Ernesto Forte; Concetta Schiano; Carlo Cavaliere; Carlo Tedeschi; Andrea Soricelli; Marco Salvatore; Claudio Napoli
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 3.  Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.

Authors:  Alireza Nazari; Hossein Khorramdelazad; Gholamhossein Hassanshahi
Journal:  Int J Clin Oncol       Date:  2017-10-11       Impact factor: 3.402

4.  CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway.

Authors:  Jia-Hui Gao; Lin-Hao He; Xiao-Hua Yu; Zhen-Wang Zhao; Gang Wang; Jin Zou; Feng-Jiao Wen; Li Zhou; Xiang-Jun Wan; Da-Wei Zhang; Chao-Ke Tang
Journal:  J Lipid Res       Date:  2019-10-29       Impact factor: 5.922

5.  A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.

Authors:  Michael P Dubé; Ellen S Chan; Jordan E Lake; Brett Williams; Jennifer Kinslow; Alan Landay; Robert W Coombs; Michelle Floris-Moore; Heather J Ribaudo; Kevin E Yarasheski
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 20.999

6.  Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran.

Authors:  Zahra Heydarifard; Alijan Tabarraei; Abdolvahab Moradi
Journal:  Dis Markers       Date:  2017-10-25       Impact factor: 3.434

Review 7.  Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.

Authors:  Milton Packer
Journal:  Cardiovasc Diabetol       Date:  2018-01-08       Impact factor: 9.951

8.  The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.

Authors:  Patrick M Brunner; Mayte Suárez-Fariñas; Helen He; Kunal Malik; Huei-Chi Wen; Juana Gonzalez; Tom Chih-Chieh Chan; Yeriel Estrada; Xiuzhong Zheng; Saakshi Khattri; Annunziata Dattola; James G Krueger; Emma Guttman-Yassky
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

9.  Phenolic extracts from whole wheat biofortified bread dampen overwhelming inflammatory response in human endothelial cells and monocytes: major role of VCAM-1 and CXCL-10.

Authors:  Nadia Calabriso; Marika Massaro; Egeria Scoditti; Antonella Pasqualone; Barbara Laddomada; Maria Annunziata Carluccio
Journal:  Eur J Nutr       Date:  2019-10-17       Impact factor: 5.614

10.  Association of SDF1 and MMP12 with Atherosclerosis and Inflammation: Clinical and Experimental Study.

Authors:  María Marcos-Jubilar; Josune Orbe; Carmen Roncal; Florencio J D Machado; José Antonio Rodriguez; Alejandro Fernández-Montero; Inmaculada Colina; Raquel Rodil; Juan C Pastrana; José A Páramo
Journal:  Life (Basel)       Date:  2021-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.